治験用バイオリポジトリ・アーカイブソリューションの世界市場：市場規模・シェア・動向分析 (サービス別・製品別・相別・地域別・セグメント別、2025年～2030年)

治験用バイオリポジトリ・アーカイブソリューション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の治験用バイオリポジトリ・アーカイブソリューションの市場規模は、2025年から2030年にかけてCAGR 8.18%を記録し、2030年には70億1,000万米ドルに達すると予測されています。

これは主に、治験 (臨床試験) における生物学的試料管理の重要性が高まり、データ収集と報告を効率化したいという要望によるものです。加えて、精密医療、個別化医療、ゲノム医療の拡大、研究開発費の増加、実験室試料管理にLIMS (Laboratory Information Management System) のようなソフトウェアを採用することでデータ収集と報告を容易にする努力は、すべて業界の成長を促進する重要な要因です。

複数の規制機関が、生物試料保管施設の運営におけるベストプラクティスを助言・開発しています。国際生物・環境保管学会 (International Society for Biological and Environmental Repositories) は、世界レベルでの生物保管手順の標準化においてその地位を強化しています。米国病理学会 (College of American Pathologists) は、バイオ保管施設の実務を標準化するために、厳格な規制を遵守する最初のバイオ保管施設認定スキームを確立しました。国際標準化機構 (ISO-20387) により、バイオ保存の能力、公平性、一貫した運営に関するバイオ保存施設基準が発行されました。

米国FDAは、医薬品の包装および保存に関連する要素を含む適正製造規範 (GMP)、適正試験所規範 (GLP)、GDP、および適正組織規範 (GTP) を制定しています。さらに、COVID-19パンデミックは、地元企業にいくつかの成長機会をもたらしました。業界における足場を固めるため、主要企業は世界市場でより大きな収益シェアを獲得するために様々な計画や方針を採用しています。重要なステップとして、主要企業は関連する第三者ベンダーとの提携を取り入れることができます。それは適切なコミュニケーションと治験用バイオリポジトリ・アーカイブソリューションの頻度と量の調整によって達成することができます。

治験用バイオリポジトリ・アーカイブソリューション市場：分析概要

• 2024年には、バイオレポジトリサービスのセグメントが市場を独占し、66.91%の収益シェアを占めました。同分野の成長は、再生医療、個別化医療、がんゲノム研究など、効果的な保管・流通・処理ソリューションを必要とする先端療法の研究開発の増加に起因しています。
• 製品別に見ると、市場は前臨床製品と臨床製品に区分されます。2024年、臨床製品セグメントは治験用バイオリポジトリ・アーカイブソリューション市場で63.40%の最大収益シェアを占めました。
• 相別 (フェーズ別) に見ると、市場は前臨床、第I相、第II相、第III相、第IV相に区分されます。前臨床セグメントは、2024年に36.60%の最大の収益シェアを占めました。このセグメントの成長は、データの完全性と透明性を重視する傾向が強まっていることが考えられます。
• 北米の治験用バイオリポジトリ・アーカイブソリューション市場は、2024年に47.99%の最大シェアを占めました。臨床試験件数の増加と、既存サービスの拡大を目指す同地域の複数の市場プレーヤーが、治験用バイオリポジトリ・アーカイブソリューションの成長にさらに貢献しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 治験用バイオリポジトリ・アーカイブソリューション市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 治験用バイオリポジトリ・アーカイブソリューション市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 治験用バイオリポジトリ・アーカイブソリューション市場：サービス別の推定と動向分析

• 世界の治験用バイオリポジトリ・アーカイブソリューション市場：セグメントダッシュボード、サービス別
• 世界の治験用バイオリポジトリ・アーカイブソリューション市場：変動分析、サービス別
• サービス別 (2018～2030年)
• バイオレポジトリサービス
  • バイオレポジトリサービス市場 (2018～2030年)
  • 倉庫保管
  • 搬送
  • 試料処理
  • その他
• アーカイブソリューションサービス
  • アーカイブソリューションサービス市場 (2018～2030年)
  • データベース用インデックス作成・管理
  • スキャン・破壊

第5章 治験用バイオリポジトリ・アーカイブソリューション市場：製品別の推定と動向分析

• 世界の治験用バイオリポジトリ・アーカイブソリューション市場：セグメントダッシュボード、製品別
• 世界の治験用バイオリポジトリ・アーカイブソリューション市場：変動分析、製品別
• 製品別 (2018～2030年)
• 前臨床製品
  • 前臨床製品市場 (2018～2030年)
• 臨床製品
  • 臨床製品市場 (2018～2030年)
  • 人体組織
  • 臓器
  • 幹細胞
  • その他の生体試料

第6章 治験用バイオリポジトリ・アーカイブソリューション市場：相別の推定と動向分析

• 世界の治験用バイオリポジトリ・アーカイブソリューション市場：セグメントダッシュボード、相別
• 世界の治験用バイオリポジトリ・アーカイブソリューション市場：変動分析、相別
• 相別 (2018～2030年)
• 前臨床
  • 前臨床市場 (2018～2030年)
• 第I相
  • 第I相市場 (2018～2030年)
• 第II相
  • 第II相市場 (2018～2030年)
• 第III相
  • 第III相市場 (2018～2030年)
• 第IV相
  • 第IV相市場 (2018～2030年)

第7章 治験用バイオリポジトリ・アーカイブソリューション市場：地域別の推定と動向分析

• 市場シェア分析：地域別 (2024年・2030年)
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 企業別の市場シェア分析 (2023年/24年)
• 企業プロファイル
  • Medpace
  • American Type Culture Collection (ATCC)
  • Cell&Co BioServices (Cryoport)
  • Brooks Life Sciences (Azenta, Inc.)
  • Patheon (Thermo Fisher Scientific, Inc.)
  • Precision Medicine Group, LLC.
  • Labcorp Drug Development
  • Q2 Solutions
  • LabConnect
  • Charles River Laboratories

第9章 主な推奨事項

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
• Table 4 North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 5 North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 6 North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 7 U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 8 U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 9 U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 10 Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 11 Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 12 Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 13 Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 14 Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 15 Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 16 Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
• Table 17 Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 18 Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 19 Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 20 UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 21 UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 22 UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 23 Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 24 Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 25 Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 26 France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 27 France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 28 France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 29 Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 30 Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 31 Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 32 Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 33 Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 34 Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 35 Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 36 Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 37 Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 38 Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 39 Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 40 Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 41 Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 42 Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 43 Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 48 Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 49 Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 50 Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 51 China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 52 China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 53 China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 54 India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 55 India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 56 India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 57 Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 58 Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 59 Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 60 South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 61 South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 62 South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 63 Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 64 Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 65 Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 66 Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
• Table 67 Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 68 Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 69 Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 70 Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 71 Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 72 Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 73 Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 74 Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 75 Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 76 Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 77 Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 78 Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 83 South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 84 South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 85 South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 89 UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 90 UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 91 UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
• Table 92 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
• Table 93 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
• Table 94 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Commodity flow analysis
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD model sizing & forecasting
• Fig. 10 Bottom-up approach
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot 1
• Fig. 13 Segment snapshot 2
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Parent market outlook, 2023 (USD Billion)
• Fig. 16 Ancillary market outlook, 2023 (USD Billion)
• Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
• Fig. 18 Porter's five forces analysis
• Fig. 19 PESTEL analysis
• Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
• Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
• Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
• Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
• Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
• Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
• Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Regional Marketplace: Key Takeaways
• Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Fig. Key country dynamics
• Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Key country dynamics
• Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Key company categorization
• Fig. 100 Service heat map analysis
• Fig. 101 Strategic framework

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 8.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

• In 2024, the biorepository services segment dominated the market, accounting for a revenue share of 66.91%. The segment growth can be attributed to the rise in R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, which require effective storage, distribution, and processing solutions.
• On the basis of the product segment, the market is segmented into preclinical products and clinical products. In 2024, the clinical products segment accounted for the largest revenue share of 63.40% in the clinical trial biorepository & archiving solutions market.
• On the basis of phase segment, the market is segmented to preclinical, phase I, phase II, phase III, and phase IV. The preclinical segment accounted for the largest revenue share of 36.60% in 2024. The segment growth can be growing emphasis on data integrity & transparency.
• North America clinical trial biorepository & archiving solutions market accounted for the largest share of 47.99% in 2024. The increase in the number of clinical trials and several market players in the region aiming to expand their existing services are further contributing to the growth of clinical trial biorepository & archiving solutions.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Product
  • 1.2.3. Phase
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing number of pharmaceutical and biotechnology companies
    • 3.2.1.2. Growing disease variation and prevalence
    • 3.2.1.3. Increasing R&D investments
    • 3.2.1.4. Growth in the CRO market
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulations for new drug development
    • 3.2.2.2. Rising cost of clinical trials
• 3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis

• 4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
• 4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
• 4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. Biorepository Services
  • 4.4.1. Biorepository Services Market, 2018 to 2030 (USD Million)
  • 4.4.2. Warehousing & Storage
    • 4.4.2.1. Warehousing & Storage Market, 2018 to 2030 (USD Million)
  • 4.4.3. Transportation
    • 4.4.3.1. Transportation Market, 2018 to 2030 (USD Million)
  • 4.4.4. Sample Processing
    • 4.4.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market, 2018 to 2030 (USD Million)
• 4.5. Archiving Solution Services
  • 4.5.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
  • 4.5.2. Database Indexing and Management
    • 4.5.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
  • 4.5.3. Scanning & Destruction
    • 4.5.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis

• 5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
• 5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
• 5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product, 2018 - 2030
• 5.4. Preclinical Products
  • 5.4.1. Preclinical Products Market, 2018 to 2030 (USD Million)
• 5.5. Clinical Products
  • 5.5.1. Clinical Products Market, 2018 to 2030 (USD Million)
  • 5.5.2. Human Tissue
    • 5.5.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
  • 5.5.3. Organs
    • 5.5.3.1. Organs Market, 2018 to 2030 (USD Million)
  • 5.5.4. Stem Cells
    • 5.5.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
  • 5.5.5. Other Biospecimens
    • 5.5.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis

• 6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
• 6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
• 6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
• 6.4. Preclinical
  • 6.4.1. Preclinical conditions Market, 2018 to 2030 (USD Million)
• 6.5. Phase I
  • 6.5.1. Phase I Market, 2018 to 2030 (USD Million)
• 6.6. Phase II
  • 6.6.1. Phase II Market, 2018 to 2030 (USD Million)
• 6.7. Phase III
  • 6.7.1. Phase III Market, 2018 to 2030 (USD Million)
• 6.8. Phase IV
  • 6.8.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Share Analysis, 2023/24
• 8.3. Company Profiles
  • 8.3.1. Medpace
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. American Type Culture Collection (ATCC)
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Cell&Co BioServices (Cryoport)
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Brooks Life Sciences (Azenta, Inc.)
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Patheon (Thermo Fisher Scientific, Inc.)
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Precision Medicine Group, LLC.
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Labcorp Drug Development
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Q2 Solutions
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. LabConnect
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Charles River Laboratories
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives

Chapter 9 Key Recommendations